The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular and immunophenotypic predictors of response to azacitidine (aza) as frontline therapy for acute myeloid leukemia (AML).
 
Michael Keith Alister Zimmerman
No Relationships to Disclose
 
Michael Richard Grunwald
Stock and Other Ownership Interests - Medtronic
Consulting or Advisory Role - Alexion Pharmaceuticals; Incyte
Research Funding - Amgen (Inst); FORMA Therapeutics (Inst); Incyte (Inst); Janssen (Inst)
 
James Thomas Symanowski
Consulting or Advisory Role - Antigen Express; Astellas Pharma; Endocyte (Inst); Lilly; ProNAi; Ra Pharma (Inst)
 
Jonathan Michael Gerber
Consulting or Advisory Role - Alexion Pharmaceuticals; Spectrum Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent Pending